In a tight competitive market, where industry-specific software is a crucial facilitator of a process, offshoring help desk support is crucial for maintaining uptime and competitive effectiveness. A consolidated help desk capability, combining on-campus and field support services, is a more scalable, cost-effective solution. KPO functions may highlight intellectual property or patent research, R&D in pharmaceuticals and biotechnology, data mining, database creation. When looking to outsource a help desk/support function, seek a provider with industry expertise, software expertise, scalable help desk capabilities and ongoing investment into components that continue to reduce the buyer's cost of the service.

The evolution and maturity of the Indian services sector has made this wave in the global offshoring scene. Cost savings, operational efficiencies, access to a highly talented workforce and improved quality are all underlying expectations in offshoring Pharmaceutical & Healthcare Services to India.

The growing trend of field among the companies today makes companies to return what they can do best and offshoring rest of the works. Many big corporations have found out that by offshoring their claims processing and risk management. KPO strikes it rich in a new breed of knowledge-based offshoring as the global corporations move the process like intellectual property researches to the offshore locations. Knowledge process offshoring (KPO) embraces the companies by providing them with a higher-end research and analytical based services in a variety of business areas.

Knowledge process offshoring includes services such as basic data research, market research, integration and management, equity research, engineering design, medical content and services, pharmaceuticals, biotechnology, legal support, intellectual property research. Our staff group have specialised knowledge in Pharmaceutical & Healthcare verticals. Moving knowledge processes to offshore locations offers a compelling value proposition as it helps overseas firms to cut costs significantly. If you are considering offshoring your processes, or would just like to know more about the various KPO services that can be outsourced to us in India, contact our KPO cell immedialtely. Contact Us and our customer service representatives will get back to you soon. We have specialized departments that focus on various areas of Knowledge Processing offshoring.

Pharmaceutical - KPO can be further done on these focus areas:

Sales and Marketing
Drug Testing
Clinical Trials - Animals
Clinical Trials - Volunteers
Research and Development

Pharmaceutical KPO - Sales & Marketing:

Medical advances and competition in the pharmaceutical industry are driving an incredible number of sales initiatives aimed at influencing physicians' prescribing habits. Managed care drives doctors to see more patients each day; so the knowledge sales reps convey to physicians about new FDA-approved drugs is a valuable benefit, eliminating hours of physician research. Yet, a high-prescribing physician may have 50 or more sales reps calling on a regular basis. Many now place limits on sales visitations, resulting in sales calls lasting, on average, two to four minutes.

"In the case of a new product launch, two weeks' lead time against a competitor's product can make the difference between a blockbuster and an also-ran," Reps depend on technology to inform them of doctors they are to call on the next day and which drugs to talk about. Their agenda also includes data collection regarding a doctor's specialty and prescribing habits, changes in payer plans or hospitals where the physician is on staff, as well as new doctors. In such an environment, SFA and CRM technology are crucial competitive advantage tools.

One Call--That's All

Pharmaceutical companies have long outsourced their internal help desk process to providers with the requisite infrastructure and expertise; but field support for their sales reps has been handled by pharma software vendors understanding the SFA applications as well as the pharmaceutical selling environment. Unfortunately, this dual model--which is expensive--places a sales rep in the position of having to place several support calls, not knowing whether the problem is in the system, network or software. Until now, there was no other option.

Pharmaceutical KPO - Clinical Trial

Pharmaceutical and biotechnology companies are increasingly turning to contract research to control expenses and create greater operational efficiencies. This KPO helps companies decide the capabilities, partnerships, and tools to meet changing market needs. In addition, the service helps clinical trial sponsors, KPOs, IT vendors, and life science vendors understand trends and future directions in KPO spending on technology.

Pharmaceutical-KPO partnership models are on with a significant and paradigm shift and are that companies develop plans for KPOs. We believe sponsors will continue to seek KPOs that have minimum overhead, excel at deliverables, offer domain and technology expertise, and standardise quality of business.

Pharma Clinical Trials

Medicines are being developed for disease treatment . Infact its a complex process with many phases of research and development before a new medicine can be taken for commercial production and made available in trade market. New drug will be extensively investigated before it is thought to be safe to be given to humans. Clinical trials play a vital role in the development of new medicines.

In Phase I trials a drug is tested for the first time in a small group of healthy volunteers mainly to determine the early safety profile as well as to gather information on the pattern of drug distribution and absorption, metabolism and other pharmacologic actions of the drug in the body. These studies are carried out at dedicated research facilities.

In Phase II clinical trials the drug is tested for the first time in patients with the actual disease condition of interest. In these types of trials information is collected on the initial efficacy of the drug, its optimal dosage and further details concerning its safety. Phase II clinical trials are carried out at multiple investigator sites and are often international.

Phase III clinical trials are large scale, multi-center studies that are carried out in a large number of patients with the target disease. In these types of studies it is important to gather enough data to statistically demonstrate the efficacy of the drug and further safety information. This information is required by the regulatory authorities, who will examine in it in deciding whether to approve the new medicine in their country.

In Phase IV, even after a drug has been approved, clinical studies continue to be conducted in order to gather more information on the drug used in the general population. These types of studies are known as Phase IIIb or Phase IV clinical trials. They are structured to obtain long-term safety data on the drug in specific or additional patient populations, data for different formulations or even to gather economic information on the use of the new drug.

On the cutting edge of delivering effective IT solutions, eCleave will address this limbo.